Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.315 USD | +3.54% | -8.98% | -2.19% |
Apr. 24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PRECIGEN, INC. | Other Pharmaceuticals | -1.55% | -10.56% | -5.22% | +19.81% | -70.94% | 321M |
- Stock Market
- Equities
- PGEN Stock
- Charts Precigen, Inc.
- Relative Strength Chart